EUVIMEDEUVIMED entdecken
Crossref

Targeting a Pathogenic Variant Creating an Upstream AUG in the ENG 5′ Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression

Mathilde Doisy, Aris Gaci, Omar Soukarieh, Carole Proust, David-Alexandre Trégouët, Aurélie Goyenvalle

Nucleic Acid Therapeutics · 2026

DOI: 10.1177/21593337251396711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2026. Verfasst von Mathilde Doisy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, UVSQ, Inserm, Versailles, France. Hauptthemen laut MEDLINE: 5' Untranslated Regions, Oligonucleotides, Antisense, Endoglin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Fondation Lefoulon Delalande, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants creating upstream open reading frames (uORFs) in the 5′ untranslated region (5′UTR) of the ENG gene can disrupt translation from the main ORF and contribute to hereditary hemorrhagic telangiectasia (HHT). This is the case of the ENG c.-79C>T that introduces a uAUG shown to decrease endoglin expression and associates with HHT. Here, we investigated whether 2′-O-methyl (2′OMe) antisense oligonucleotides (ASOs) could restore protein levels by masking this aberrant uAUG or by targeting predicted secondary structures within the ENG 5′UTR. Several ASOs of varying lengths and backbone chemistries (full phosphodiester or full phosphorothioate) were designed to target the mutant region. Their effects were evaluated in HeLa cells transfected and in HUVECs transduced with wild-type or mutant ENG constructs. Transfection efficiency was verified by MALAT1 knockdown via qPCR, and endoglin protein levels were assessed by Western blot. Despite efficient ASO delivery and optimized experimental conditions, no reproducible increase in endoglin expression was observed upon ASO treatment. These findings highlight the limitations of steric-blocking ASOs targeting 5′UTR variants and underscore the need for deeper mechanistic understanding of uORF-mediated translational regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5' Untranslated RegionsOligonucleotides, AntisenseEndoglinHumansHeLa CellsOpen Reading FramesHuman Umbilical Vein Endothelial CellsProtein BiosynthesisMutation

Stichwörter der Autor:innen

5′ENG geneantisense oligonucleotideshereditary hemorrhagic telangiectasiauntranslated regionupstream AUG

Substanzen

5' Untranslated RegionsOligonucleotides, AntisenseEndoglinENG protein, human

Autor:innen und Institutionen

  • Université Paris-Saclay, UVSQ, Inserm, Versailles, France.
  • Université de Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France.

Förderung

  • Fondation Lefoulon Delalande
  • Agence Nationale de la Recherche

Zitieren

APA

Doisy, M., Gaci, A., Soukarieh, O., Proust, C., Trégouët, D. A., & Goyenvalle, A. (2026). Targeting a Pathogenic Variant Creating an Upstream AUG in the ENG 5′ Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression. Nucleic Acid Therapeutics. https://doi.org/10.1177/21593337251396711

Vancouver

Doisy M, Gaci A, Soukarieh O, Proust C, Trégouët DA, Goyenvalle A. Targeting a Pathogenic Variant Creating an Upstream AUG in the ENG 5′ Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression. Nucleic Acid Therapeutics. 2026. doi:10.1177/21593337251396711

BibTeX
@article{Doisy2026,
  author = {Doisy, Mathilde and Gaci, Aris and Soukarieh, Omar and Proust, Carole and Trégouët, David-Alexandre and Goyenvalle, Aurélie},
  title = {Targeting a Pathogenic Variant Creating an Upstream AUG in the ENG 5′ Untranslated Region with Antisense Oligonucleotides Fails to Restore Protein Expression},
  journal = {Nucleic Acid Therapeutics},
  year = {2026},
  doi = {10.1177/21593337251396711}
}
Kostenlos starten →